Carrie Oser's guest appearances

Carrie Oser

Behind the Blue

David Rosenberg

Eli Capilouto

Melissa Hogan

Jennifer Hunter

Hannah Pittard

Christine Harper

Jason Brooks

Joe Monroe

Mark Williams

Jen Smith

Peter Nelson

Jill Smith

George Wright

Nicole Martin

Sarah Johnson

OwlTail

LEXINGTON, Ky. (Jan. 21, 2020) – The University of Kentucky recently received $3 million from the National Institute on Drug Abuse and National Institute on General Medical Sciences to fund new opioid-related research in the criminal justice system. Known as the Geographic variation in Addiction Treatment (GATE) study, the 5-year project is led by Carrie Oser, professor of sociology in the UK College of Arts &amp; Sciences. Oser and her colleagues will be focusing on the factors that influence a person’s decision to use one of the three FDA-approved medications for the treatment of opioid use disorder (OUD) – methadone, buprenorphine and extended-release naltrexone. Although research shows that these medications are highly effective at reducing opioid use, infectious disease transmission, and drug-related criminal behavior, uptake of these medications is low – only about 7% of people with OUD receive medications – and more than half of KY counties do not have any providers who prescribe medications for OUD.  It is even more challenging for those involved in the criminal justice system. In the past few years, the Kentucky Department of Corrections has addressed this issue by making naltrexone available inside their institutions and is currently piloting expansion at three prisons by offering buprenorphine to individuals with OUD that meet clinical and medical protocols. On this episode of Behind the Blue, Oser talks with UKPR’s Allison Perry about the GATE study and its goals, to identify how a person’s individual characteristics, personal networks and structural factors influence their decision whether or not to take medication for OUD both during incarceration and following release, and it will specifically look at the differences between urban and rural populations. While other studies have looked at individual and structural factors as predictors of medication use, this study is unique in its focus on the people surrounding the person with OUD and how their support – or lack thereof – and opinions influences decisions on taking medication. "Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email BehindTheBlue@uky.edu or tweet your question with #BehindTheBlue. To discover what’s wildly possible at the University of Kentucky, click here.

LEXINGTON, Ky. (Jan. 21, 2020) – The University of Kentucky recently received $3 million from the National Institute on Drug Abuse and National Institute on General Medical Sciences to fund new opioid-related research in the criminal justice system. Known as the Geographic variation in Addiction Treatment (GATE) study, the 5-year project is led by Carrie Oser, professor of sociology in the UK College of Arts &amp; Sciences. Oser and her colleagues will be focusing on the factors that influence a person’s decision to use one of the three FDA-approved medications for the treatment of opioid use disorder (OUD) – methadone, buprenorphine and extended-release naltrexone. Although research shows that these medications are highly effective at reducing opioid use, infectious disease transmission, and drug-related criminal behavior, uptake of these medications is low – only about 7% of people with OUD receive medications – and more than half of KY counties do not have any providers who prescribe medications for OUD.  It is even more challenging for those involved in the criminal justice system. In the past few years, the Kentucky Department of Corrections has addressed this issue by making naltrexone available inside their institutions and is currently piloting expansion at three prisons by offering buprenorphine to individuals with OUD that meet clinical and medical protocols. On this episode of Behind the Blue, Oser talks with UKPR’s Allison Perry about the GATE study and its goals, to identify how a person’s individual characteristics, personal networks and structural factors influence their decision whether or not to take medication for OUD both during incarceration and following release, and it will specifically look at the differences between urban and rural populations. While other studies have looked at individual and structural factors as predictors of medication use, this study is unique in its focus on the people surrounding the person with OUD and how their support – or lack thereof – and opinions influences decisions on taking medication. "Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email <a href="mailto:BehindTheBlue@uky.edu">BehindTheBlue@uky.edu</a> or tweet your question with #BehindTheBlue. To discover what’s wildly possible at the University of Kentucky, click <a href="http://uknow.uky.edu/campus-news/igniting-passions-achieving-what-s-wildly-possible" rel="nofollow" target="_blank">here</a>.

January 21, 2020 - Carrie Oser (Geographic variation in Addiction Treatment (GATE) study)

Nancy Schoenberg

LEXINGTON, Ky. (Sept. 21, 2018) - As the university for Kentucky, understanding and addressing the health needs of the people of the Commonwealth is the goal of many faculty, staff, clinicians and researchers. As a step toward improving health equity in the Commonwealth, the University of Kentucky Center for Health Equity Transformation (CHET) was established during the 2018 Board of Trustees meeting.  On this episode of Behind the Blue, CHET director Nancy Schoenberg and associate director Carrie Oser discuss how, through research and training, CHET will increase the number of researchers and the amount of health-equity focused research at UK. "[Kentucky] is one of several states where we see declines in life expectancy so there is a lot of work to be done. We believe that research can help inform the best practices that can support improvements in health" said Nancy Schoenberg. To learn more about the Center for Health Equity Transformation,  click here. Become a subscriber to receive new episodes of "Behind the Blue" each week. UK's latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email BehindTheBlue@uky.edu or tweet your question with #BehindTheBlue. Click here for "Behind the Blue" on iTunes.

LEXINGTON, Ky. (Sept. 21, 2018) - As the university for Kentucky, understanding and addressing the health needs of the people of the Commonwealth is the goal of many faculty, staff, clinicians and researchers. As a step toward improving health equity in the Commonwealth, the University of Kentucky Center for Health Equity Transformation (CHET) was established during the 2018 Board of Trustees meeting.  On this episode of Behind the Blue, CHET director Nancy Schoenberg and associate director Carrie Oser discuss how, through research and training, CHET will increase the number of researchers and the amount of health-equity focused research at UK. "[Kentucky] is one of several states where we see declines in life expectancy so there is a lot of work to be done. We believe that research can help inform the best practices that can support improvements in health" said <a href="https://behavioralscience.med.uky.edu/users/nesch" rel="nofollow" target="_blank">Nancy Schoenberg</a>. To learn more about the Center for Health Equity Transformation, <a href="https://med.uky.edu/sites/default/files/overview%20of%20CHET%20Schoenberg%203-13-18.pdf" rel="nofollow" target="_blank"> click here</a>. Become a subscriber to receive new episodes of "Behind the Blue" each week. UK's latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email <a href="mailto:BehindTheBlue@uky.edu">BehindTheBlue@uky.edu</a> or tweet your question with #BehindTheBlue. Click <a href="https://itunes.apple.com/us/podcast/behind-the-blue/id1114911777?mt=2" rel="nofollow" target="_blank">here</a> for "Behind the Blue" on iTunes.

September 21, 2018 - Nancy Schoenberg & Carrie Oser, UK Center for Health Equity Transformation (CHET)